Neurology 2002;58:1348-1353
© 2002 American Academy of Neurology
Effect of antiepileptic drugs on bone density in ambulatory patients
G. Farhat, MPH,
B. Yamout, MD,
M. A. Mikati, MD,
S. Demirjian, MD MPH,
R. Sawaya, MD and
G. El-Hajj Fuleihan, MD MPH
From the Calcium Metabolism and Osteoporosis Program (G. Farhat and Drs. Demirjian and El-Hajj Fuleihan) and Division of Neurology (Drs. Yamout and Sawaya), Department of Internal Medicine, and Adult and Pediatric Epilepsy Program, Department of Pediatrics (Dr. Mikati), American University of Beirut Medical Center, Lebanon.
Address correspondence and reprint requests to Dr. Ghada El-Hajj Fuleihan, Calcium Metabolism and Osteoporosis Program, American University of Beirut Medical Center, Bliss Street, Beirut, Lebanon; e-mail: gf01{at}aub.edu.lb
Background: Long-term antiepileptic drug (AED) use causes multiple abnormalities in calcium and bone metabolism that have been most extensively described in institutionalized patients. The objective is to determine the effect of AED on vitamin D levels and bone density in ambulatory patients and to compare the effects of enzyme-inducing and -noninducing AED and of single vs multiple therapy on bone density.
Methods: A cross-sectional evaluation was conducted of 71 patients (42 adults and 29 children/adolescents) on anticonvulsant therapy for at least 6 months who presented to neurologists at a tertiary referral center. Bone mineral density (BMD) as well as serum 25 hydroxy–vitamin D (25-OHD) levels were measured. A detailed questionnaire assessing calcium intake as well as previous and current intake of antiepileptic medications was administered to all patients.
Results: Over 50% of adults and children/adolescents had low 25-OHD levels, but this finding did not correlate with BMD. Antiepileptic therapy decreased BMD in adults. Generalized seizures, duration of epilepsy, and polypharmacy were significant determinants of BMD, more so at skeletal sites enriched in cortical bone. Subjects on enzyme-inducing drugs such as phenytoin, phenobarbital, carbamazepine, and primidone tended to have lower BMD than those on noninducers such as valproic acid, lamotrigine, clonazepam, gabapentin, topamirate, and ethosuximide.
Conclusion: Epilepsy and its therapy, including the newer drugs, are risk factors for low bone density, irrespective of vitamin D levels. Skeletal monitoring with the institution of appropriate therapy is indicated in patients on chronic antiepileptic therapy.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the May 14 issue to find the link for this article.
This article has been cited by other articles:
|
|
|
|
 
M. A. Mikati, N. Ataya, G. El-Hajj Fuleihan, and E. Trevathan
EPILEPSY-ASSOCIATED BONE MINERAL DENSITY LOSS SHOULD BE PREVENTED
Neurology,
March 10, 2009;
72(10):
943 - 944.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Sheth, N. Binkley, and B. P. Hermann
Progressive bone deficit in epilepsy
Neurology,
January 15, 2008;
70(3):
170 - 176.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. J. Kalkwarf, B. S. Zemel, V. Gilsanz, J. M. Lappe, M. Horlick, S. Oberfield, S. Mahboubi, B. Fan, M. M. Frederick, K. Winer, et al.
The Bone Mineral Density in Childhood Study: Bone Mineral Content and Density According to Age, Sex, and Race
J. Clin. Endocrinol. Metab.,
June 1, 2007;
92(6):
2087 - 2099.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Haneef, M. Jacobson, M.A. Mikati, L. Dib, B. Yamout, R. Sawaya, A.C. Rahi, and G. El-Hajj Fuleihan
TWO RANDOMIZED VITAMIN D TRIALS IN AMBULATORY PATIENTS ON ANTICONVULSANTS: IMPACT ON BONE
Neurology,
May 29, 2007;
68(22):
1958 - 1959.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Mikati, L. Dib, B. Yamout, R. Sawaya, A. C. Rahi, and G. E.-H. Fuleihan
Two randomized vitamin D trials in ambulatory patients on anticonvulsants: Impact on bone
Neurology,
December 12, 2006;
67(11):
2005 - 2014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Sheth and B. E. Gidal
Topical Review: Optimizing Epilepsy Management in Teenagers
J Child Neurol,
April 1, 2006;
21(4):
273 - 279.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. J. Petty, L. M. Paton, T. J. O'Brien, J. Makovey, B. Erbas, P. Sambrook, S. F. Berkovic, and J. D. Wark
Effect of antiepileptic medication on bone mineral measures
Neurology,
November 8, 2005;
65(9):
1358 - 1365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. A. Voudris, A. Attilakos, E. Katsarou, A. Garoufi, S. Dimou, A. Skardoutsou, and S. Mastroyianni
Early Alteration in Bone Metabolism in Epileptic Children Receiving Carbamazepine Monotherapy Owing to the Induction of Hepatic Drug-Metabolizing Enzymes
J Child Neurol,
June 1, 2005;
20(6):
513 - 516.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. A. Voudris, A. Attilakos, E. Katsarou, A. Garoufi, S. Dimou, A. Skardoutsou, and S. Mastroyianni
Early Alteration in Bone Metabolism in Epileptic Children Receiving Carbamazepine Monotherapy Owing to the Induction of Hepatic Drug--Metabolizing Enzymes
J Child Neurol,
June 1, 2005;
20(6):
513 - 516.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. D. Sheth
Metabolic concerns associated with antiepileptic medications
Neurology,
November 23, 2004;
63(10_suppl_4):
S24 - S29.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
R. Sankar
Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues
Neurology,
November 23, 2004;
63(10_suppl_4):
S30 - S39.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. G. CIANCIO
Medications' impact on oral health
J Am Dent Assoc,
October 1, 2004;
135(10):
1440 - 1448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Ensrud, T. S. Walczak, T. Blackwell, E. R. Ensrud, P. J. Bowman, and K. L. Stone
Antiepileptic drug use increases rates of bone loss in older women: A prospective study
Neurology,
June 8, 2004;
62(11):
2051 - 2057.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J.P. McCorry and G. El-Hajj Fuleihan
Effect of antiepileptic drugs on bone density in ambulatory patients
Neurology,
January 27, 2004;
62(2):
342 - 342.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. L. Harden
Menopause and bone density issues for women with epilepsy
Neurology,
September 1, 2003;
61(90062):
S16 - 22.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
More Evidence Associating AEDs with Bone Disease
Journal Watch Neurology,
August 9, 2002;
2002(809):
6 - 6.
[Full Text]
|
|
|
Correspondence:
Read all Correspondence
- The use of an american control group for reseach in BMD in Lebanon is Inappropriate?
- Dougall J.P. McCorry MRCP.MBChB
- Neurology Online, 26 Jul 2003
[Full text]
- Reply to McCorry
- Ghada El-Hajj Fuleihan, MD, MPH
- Neurology Online, 26 Jul 2003
[Full text]
|
